Hidradenitis Suppurativa
Advertisement
Julia Riley, MD, of Northwestern Medicine, goes in depth on racial disparities in hidradenitis suppurativa.
Dr. Adam Friedman talks about a telemedicine program designed to improve dermatologic medical care in underserved areas.
There exists a link between self-management-competency and hidradenitis suppurativa.
A study indicates a potential link between hidradenitis suppurativa and dissecting cellulitis.
Individuals with hidradenitis suppurativa face barriers to access dermatology care.
A multitude of factors lead to disparities in the treatment of hidradenitis suppurativa in Black patients.
Hidradenitis suppurativa patients see their comorbidity burden increase following diagnosis.
A study analyzed HS prevalence in Lagos, Nigeria.
Patients with hidradenitis suppurativa have an increased prevalence of anemia.
Psychosocial screenings are low among hidradenitis suppurativa patients.
Existing diagnostic criteria for hidradenitis suppurativa (HS) may not fully apply to pediatric patients.
Patients of color with HS have increased disease severity and healthcare use compared with other groups.
A recent study shows that there is a notable lack of ethnic minority representation in hidradenitis suppurativa trials.
A study found a link between disease-related factors of hidradenitis suppurativa and low educational level.
A new study shows that non-white patients with hidradenitis suppurativa have longer delays in diagnosis.
People with hidradenitis suppurativa are more likely to have bipolar disorder.
In part 2 of a 2-part interview, Cheri Frey, MD, spoke about how health care providers can address disparities in HS.
Cheri Frey, MD, a board-certified dermatologist, discusses why HS tends to disproportionately impact people of color.
Women are twice as likely to be diagnosed with HS than men.
Different clinical manifestations exist between men and women with hidradenitis suppurativa (HS).
Advertisement
630 Madison Ave.
Manalapan, NJ 07726
© 2024 Mashup Media, LLC. All rights reserved.